OUR PRODUCTS

MOBILE APPS

GENERAL INFO

MAZE

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Maze Therapeutics (MAZE) Ownership - Who owns Maze Therapeutics?

Maze Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small-molecule precision medicines for patients living with renal, cardiovascular and related metabolic, or CVRM, diseases, including obesity... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Details

Group

Domestic Stock Funds

Fundamentals

MAZE

Capitalization

566M

P/E Ratio

181.91

Risk (Beta)

N/A

Dividend Yield

N/A

Total Cash

N/A

Total Cash/Share

N/A

Total Debt

N/A

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

3.82%

Revenue

N/A

ROE

N/A

Book Value

N/A

P/B Ratio

1.94

Cash Flow

N/A

Earnings

N/A

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

N/A

Current Ratio

N/A

Current Revenue Per Employee

N/A

Dividends Per Share - Security

N/A

EBITDA

N/A

Float

N/A

Float - Current

N/A

Gross Income Margin

N/A

Revenue To Assets

N/A

Shares Held By Institutions

71.7M

Shares Outstanding - Current

43.8M

Total Liabilities

N/A

Total Volume MTD

N/A

Value

-1

Gain YTD

N/A

View a ticker or compare two or three

Compare

Interact to see
Advertisement

A.I.Advisor

published price charts

View to see Real Time Patterns for MAZE (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details